Usefulness of consecutive faecal calprotectin measurements to predict relapse in inflammatory bowel disease patients under maintenance treatment with anti-TNF therapy: a prospective longitudinal cohort study

被引:0
|
作者
Ferreiro, R. [1 ]
Barreiro-de Acosta, M. [1 ]
Lorenzo, A. [1 ]
Dominguez-Munoz, J. E. [1 ]
机构
[1] Univ Hosp Santiago de Compostela, Gastroenterol, Santiago, Spain
来源
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
P116
引用
收藏
页码:S147 / S147
页数:1
相关论文
共 50 条
  • [1] Usefulness of Consecutive Fecal Calprotectin Measurements to Predict Relapse in Inflammatory Bowel Disease Patients Under Maintenance Treatment With Anti-TNF Therapy: A Prospective Longitudinal Cohort Study
    Ferreiro, Rocio
    Barreiro-de Acosta, M.
    Lorenzo-Gonzalez, Aurelio
    Dominguez-Munoz, Enrique
    [J]. GASTROENTEROLOGY, 2016, 150 (04) : S420 - S420
  • [2] Accuracy of Consecutive Fecal Calprotectin Measurements to Predict Relapse in Inflammatory Bowel Disease Patients Under Maintenance With Anti-TNF Therapy A Prospective Longitudinal Cohort Study
    Ferreiro-Iglesias, Rocio
    Barreiro-de Acosta, Manuel
    Lorenzo-Gonzalez, Aurelio
    Dominguez-Munoz, Juan E.
    [J]. JOURNAL OF CLINICAL GASTROENTEROLOGY, 2018, 52 (03) : 229 - 234
  • [3] Usefulness of monocytosis as biomarker to predict relapse in inflammatory bowel disease patients in remission under maintenance treatment with anti-TNF drugs: A prospective longitudinal cohort study
    Ferreiro, R.
    Lopez-Diaz, J.
    Baston, I.
    Dominguez-Munoz, J. E.
    Barreiro-de Acosta, M.
    [J]. JOURNAL OF CROHNS & COLITIS, 2018, 12 : S213 - S214
  • [4] MONOCYTOSIS AS A BIOMARKER TO PREDICT RELAPSE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE UNDER MAINTENANCE TREATMENT WITH ANTI-TNF DRUGS: A PROSPECTIVE, LONGITUDINAL COHORT STUDY
    Ferreiro, Rocio
    Lopez-Diaz, Javier
    Barreiro, Manuel
    Enrique Dominguez-Munoz, J.
    [J]. GASTROENTEROLOGY, 2017, 152 (05) : S394 - S394
  • [5] Lipid profile in inflammatory bowel disease under maintenance wih anti-TNF: a prospective longitudinal cohort study
    Ferreiro, R.
    Lopez-Diaz, J.
    Lorenzo, A.
    Dominguez-Munoz, E.
    Barreiro-de Acosta, M.
    [J]. JOURNAL OF CROHNS & COLITIS, 2017, 11 : S180 - S180
  • [6] Accuracy of Consecutive Fecal Calprotectin Measurements to Predict Relapse in Inflammatory Bowel Disease Patients
    Dai, Cong
    Cao, Qin
    Jiang, Min
    [J]. JOURNAL OF CLINICAL GASTROENTEROLOGY, 2019, 53 (04) : 314 - 314
  • [7] Response to Anti-TNF Therapy in Hispanics With Inflammatory Bowel Disease: A Prospective Cohort Study
    Bonthala, Nirupama
    Demisse, Rahel
    Rezapour, Mona
    Hwang, Caroline
    [J]. GASTROENTEROLOGY, 2015, 148 (04) : S865 - S865
  • [8] Reply to: Accuracy of Consecutive Fecal Calprotectin Measurements to Predict Relapse in Inflammatory Bowel Disease Patients
    Ferreiro-Iglesias, Rocio
    Barreiro-de Acosta, Manuel
    Enrique Dominguez-Munoz, Juan
    [J]. JOURNAL OF CLINICAL GASTROENTEROLOGY, 2019, 53 (04) : 315 - 316
  • [9] Longitudinal Outcomes of Anti-TNF Therapy in the Treatment of Inflammatory Bowel Disease
    Roney, Andrew R.
    Orr, Dupre
    Barghi, Armeen
    Cusumano, Vivy
    Limketkai, Berkeley
    Sauk, Jenny
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10): : S768 - S769
  • [10] Infliximab but not adalimumab drug levels predict faecal calprotectin response in Inflammatory Bowel Disease patients on dose-intensified anti-TNF therapy
    Noack, S.
    Little, R.
    Vaz, K.
    Ward, M.
    Sparrow, M.
    [J]. JOURNAL OF CROHNS & COLITIS, 2021, 15 : S471 - S472